Brief: Oryzon 9-Month Net Loss At 1.3 Mln Euros
Nov 7 (Reuters) - Oryzon Genomics SA ORY.MC: 9-MONTH NET LOSS 1.3 MILLION EUROS Source text: ID:nCNM3gwgbs Further company coverage: ORY.MC (Gdansk Newsroom) ((Gdansk.newsroom@thomsonreuters.com;))
Recent news on ORYZON Genomics SA
See all newsBrief: Oryzon Gets New Patent Grants For Vafidemstat In Four Countries
Brief: Oryzon Gets EMA Approval To Start Phase II Study Of Vafidemstat For PMS Treatment
Spanish stocks - Factors to watch on Aug 31
Brief: Oryzon Gets U.S. Patent Allowance For Iadademstat And Gilteritinib Drug Combo Application
Spanish stocks - Factors to watch on July 28